Tomas Kiselak
Board Member
Dianthus Therapeutics, Inc. /DE/ (DNTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tomas Kiselak
Tomas Kiselak is recorded as Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Tomas Kiselak was appointed Board of Directors, effective September 11, 2023.
“In accordance with the Merger Agreement, immediately after the closing of the Merger on September 11, 2023, the size of the Board of Directors was fixed at eight members, consisting of two members designated by the Company, who are Alison F. Lawton and Anne McGeorge, and six members designated by OpCo, who are Marino Garcia, Leon O. Moulder, Jr., Tomas Kiselak, Lei Meng, Paula Soteropoulos and Jonathan Violin, Ph.D.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dianthus Therapeutics, Inc. /DE/
Other people whose current roles at this company are on record from its filings.
- Marino Garcia CEO, Board Member
- Alison F. Lawton Chairman
- Leon O. Moulder, Jr. Chairman, Board Member
- Ryan Savitz CFO, Board Member
- Steve Mahoney CFO
- Edward Carr Chief Accounting Officer, Board Member
- Adam Veness Board Member
- Anne McGeorge Board Member
- Jonathan Violin Board Member
- Jonathan Violin, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.